Standardization of the preanalytical phase of DNA extraction from fixed tissue for next-generation sequencing analyses.
DNA extraction
FFPE
Next-Generation sequencing
Preanalytics
Quality control
Tissue
Journal
New biotechnology
ISSN: 1876-4347
Titre abrégé: N Biotechnol
Pays: Netherlands
ID NLM: 101465345
Informations de publication
Date de publication:
25 Jan 2020
25 Jan 2020
Historique:
received:
05
02
2019
revised:
24
07
2019
accepted:
28
07
2019
pubmed:
10
8
2019
medline:
25
2
2020
entrez:
10
8
2019
Statut:
ppublish
Résumé
Next-generation sequencing (NGS) analyses on DNA derived from archived Formalin-Fixed Paraffin-Embedded (FFPE) clinical material can provide a powerful tool in oncology research and clinical diagnostics. Although several studies have established that NGS can be performed using DNA from FFPE tissue, the accuracy and reproducibility of such analyses, as well as their robustness to the biomolecular quality of the samples used, remains a matter of debate. Excellent reviews have recently been published, providing evidence-based best practices for FFPE DNA extraction. Alternative fixatives exist, although their implementation in clinical practice is difficult. In this article, we present (i) a review of fixed tissue DNA preanalytics with a special focus on DNA extraction and fixed tissue sample qualification and (ii) results from comparisons between different methods of DNA extraction from tissue samples that have been fixed or stabilized by different methods, in terms of NGS metrics and different DNA quality metrics.
Identifiants
pubmed: 31398512
pii: S1871-6784(19)30046-9
doi: 10.1016/j.nbt.2019.07.005
pii:
doi:
Substances chimiques
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-61Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.